March 30, 2013 1:30pm
My intent in these communications is to keep our constituents well informed concerning Scimitar's code of ethics, governance, disclosure and transparency practices with regard to issues of trust and its safeguards.
March 30, 2013 1:30pm
My intent in these communications is to keep our constituents well informed concerning Scimitar's code of ethics, governance, disclosure and transparency practices with regard to issues of trust and its safeguards.
35 companies, 1 interpreter!
Insight, foresight and recommendation
6 hours 39 min ago
RegMed Investors (RMi) - Q4/23 & FY23 Cell and Gene Therapy Earnings Scorecard Results
6 hours 44 min ago
RegMed Investors (RMi) Closing Bell: a session of cell and gene therapy sector shifting share pricing
13 hours 57 min ago
RegMedInvestors (RMi) Research Note – finance: bluebird bio (BLUE)Secures up to $175 M Debt Financing with Hercules Capital
15 hours 49 min ago
RegMed Investors’ (RMi) pre-open: which way to safety?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors